Cargando…
Prognostic value of genomic damage in non-small-cell lung cancer.
Genomic alterations have been analysed in 65 non-small-cell lung cancer (NSCLC) tissue samples by using the arbitrarily primed polymerase chain reaction (AP-PCR), which is a PCR-based genomic fingerprinting. We have shown that AP-PCR may be applied as a useful and feasible practical method for detec...
Autores principales: | de Juan, C., Iniesta, P., Vega, F. J., Peinado, M. A., Fernandez, C., Caldés, T., Massa, M. J., López, J. A., Sánchez, A., Torres, A. J., Balibrea, J. L., Benito, M. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
1998
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2150368/ https://www.ncbi.nlm.nih.gov/pubmed/9667677 |
Ejemplares similares
-
p53 exon 5 mutations as a prognostic indicator of shortened survival in non-small-cell lung cancer.
por: Vega, F. J., et al.
Publicado: (1997) -
Prognostic factors and classification in multiple myeloma.
por: San Miguel, J. F., et al.
Publicado: (1989) -
Relationship between 3p deletions and telomerase activity in non-small-cell lung cancer: prognostic implications
por: Iniesta, P, et al.
Publicado: (2004) -
Educación médica en tiempo de pandemia: el caso de la enfermedad por coronavirus 2019 (COVID-19)
por: Sánchez-Duque, Jorge A.
Publicado: (2020) -
Atención Temprana, prácticas centradas en la familia y logopedia
por: Sánchez, Francisco Alberto GarcÃa
Publicado: (2020)